Presentation Stopping Clopidogrel 1 year After Drug-Eluting Stent (DES) Implantation: Is It Safe? Presenter: Nalyaka Sambu January 03, 2012 REGISTER for free or LOG IN to view this content CAD Pharma Presentation TCT 2012 Up Next Presentation Relative Dose and Vascular Response After Resolute Zotarolimus-Eluting Stent Implantation: A Dosimetric 3D-Intravascular Ultrasound Study. Presenter: Hideki Kitahara January 03, 2012 More slides + Presentation Reconsidering Outcomes After Transcatheter Aortic Valve Implantation Following The Valve Academic Research Consortium Definitions Presenter: Moritz Seiffert January 03, 2012 Presentation Vertebral Angioplasty Stenting. Are Protection Devices Useful? Presenter: Michel Henry January 03, 2012 We Recommend
Presentation Relative Dose and Vascular Response After Resolute Zotarolimus-Eluting Stent Implantation: A Dosimetric 3D-Intravascular Ultrasound Study. Presenter: Hideki Kitahara January 03, 2012
Presentation Reconsidering Outcomes After Transcatheter Aortic Valve Implantation Following The Valve Academic Research Consortium Definitions Presenter: Moritz Seiffert January 03, 2012
Presentation Vertebral Angioplasty Stenting. Are Protection Devices Useful? Presenter: Michel Henry January 03, 2012